| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic endopeptidase activity, intramembrane cleaving | 1.44e-04 | 8 | 46 | 2 | GO:0042500 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 4.64e-04 | 14 | 46 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.57e-04 | 465 | 46 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 7.76e-04 | 18 | 46 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR52B4 CD300LF OR4K17 GPR82 KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1 GLP2R | 8.50e-04 | 1353 | 46 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 8.66e-04 | 19 | 46 | 2 | GO:0042577 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.06e-03 | 21 | 46 | 2 | GO:0035613 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | PSEN1 PSEN2 CD300LF KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 | 7.22e-06 | 615 | 46 | 9 | GO:0002764 |
| GeneOntologyBiologicalProcess | protein catabolic process at postsynapse | 2.91e-05 | 4 | 46 | 2 | GO:0140249 | |
| GeneOntologyBiologicalProcess | hair follicle maturation | 3.64e-05 | 29 | 46 | 3 | GO:0048820 | |
| GeneOntologyBiologicalProcess | protein catabolic process at synapse | 7.26e-05 | 6 | 46 | 2 | GO:0140246 | |
| GeneOntologyBiologicalProcess | regulation of immune response | PSEN1 PSEN2 CD300LF KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1 DHX9 | 1.12e-04 | 1085 | 46 | 10 | GO:0050776 |
| GeneOntologyBiologicalProcess | Notch receptor processing | 2.16e-04 | 10 | 46 | 2 | GO:0007220 | |
| GeneOntologyCellularComponent | gamma-secretase complex | 1.12e-04 | 7 | 49 | 2 | GO:0070765 | |
| HumanPheno | Semantic dementia | 8.85e-05 | 7 | 11 | 2 | HP:0030219 | |
| HumanPheno | Finger agnosia | 8.85e-05 | 7 | 11 | 2 | HP:0010525 | |
| HumanPheno | Anomic aphasia | 1.51e-04 | 9 | 11 | 2 | HP:0030784 | |
| HumanPheno | Deposits immunoreactive to beta-amyloid protein | 1.51e-04 | 9 | 11 | 2 | HP:0003791 | |
| HumanPheno | Alzheimer disease | 1.51e-04 | 9 | 11 | 2 | HP:0002511 | |
| HumanPheno | Senile plaques | 2.31e-04 | 11 | 11 | 2 | HP:0100256 | |
| Domain | Peptidase_A22A | 5.68e-06 | 2 | 45 | 2 | IPR001108 | |
| Domain | Presenilin | 5.68e-06 | 2 | 45 | 2 | PF01080 | |
| Domain | ig | 6.00e-06 | 190 | 45 | 6 | PF00047 | |
| Domain | Immunoglobulin | 6.00e-06 | 190 | 45 | 6 | IPR013151 | |
| Domain | IG | 6.09e-05 | 421 | 45 | 7 | SM00409 | |
| Domain | Ig_sub | 6.09e-05 | 421 | 45 | 7 | IPR003599 | |
| Domain | Preselin/SPP | 1.18e-04 | 7 | 45 | 2 | IPR006639 | |
| Domain | PSN | 1.18e-04 | 7 | 45 | 2 | SM00730 | |
| Domain | Ig-like_dom | 1.84e-04 | 503 | 45 | 7 | IPR007110 | |
| Domain | XK_rel | 3.08e-04 | 11 | 45 | 2 | IPR018629 | |
| Domain | XK-related | 3.08e-04 | 11 | 45 | 2 | PF09815 | |
| Domain | ABC_A | 3.69e-04 | 12 | 45 | 2 | IPR026082 | |
| Domain | - | 8.47e-04 | 18 | 45 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 8.47e-04 | 18 | 45 | 2 | SM00014 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 1.05e-03 | 20 | 45 | 2 | IPR000326 | |
| Domain | PAP2 | 1.05e-03 | 20 | 45 | 2 | PF01569 | |
| Domain | IG_LIKE | 1.09e-03 | 491 | 45 | 6 | PS50835 | |
| Domain | Ig-like_fold | 1.39e-03 | 706 | 45 | 7 | IPR013783 | |
| Domain | - | 4.90e-03 | 663 | 45 | 6 | 2.60.40.10 | |
| Domain | F-box-like | 5.04e-03 | 44 | 45 | 2 | PF12937 | |
| Domain | ABC_TRANSPORTER_2 | 5.97e-03 | 48 | 45 | 2 | PS50893 | |
| Domain | ABC_tran | 5.97e-03 | 48 | 45 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 6.21e-03 | 49 | 45 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 6.46e-03 | 50 | 45 | 2 | IPR003439 | |
| Domain | FBOX | 6.97e-03 | 52 | 45 | 2 | SM00256 | |
| Domain | F-box | 1.14e-02 | 67 | 45 | 2 | PF00646 | |
| Domain | FBOX | 1.30e-02 | 72 | 45 | 2 | PS50181 | |
| Domain | DEAD | 1.34e-02 | 73 | 45 | 2 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.34e-02 | 73 | 45 | 2 | IPR011545 | |
| Domain | F-box_dom | 1.41e-02 | 75 | 45 | 2 | IPR001810 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.79e-07 | 46 | 40 | 5 | M27151 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.09e-04 | 88 | 40 | 4 | M16004 | |
| Pathway | REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3 | 2.17e-04 | 8 | 40 | 2 | M27887 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.25e-04 | 11 | 40 | 2 | M27882 | |
| Pathway | REACTOME_TGFBR3_PTM_REGULATION | 4.25e-04 | 11 | 40 | 2 | M48251 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 4.25e-04 | 11 | 40 | 2 | M47865 | |
| Pathway | WP_INCLUSION_BODY_MYOSITIS | 4.25e-04 | 11 | 40 | 2 | M42545 | |
| Pathway | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | 4.25e-04 | 11 | 40 | 2 | M2661 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 5.95e-04 | 137 | 40 | 4 | M5669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.19e-04 | 16 | 40 | 2 | M47695 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 9.19e-04 | 16 | 40 | 2 | M7257 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.04e-03 | 17 | 40 | 2 | MM14552 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.17e-03 | 18 | 40 | 2 | M524 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.29e-03 | 76 | 40 | 3 | M19832 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 1.59e-03 | 21 | 40 | 2 | M1001 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.75e-03 | 22 | 40 | 2 | M27210 | |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 2.62e-15 | 11 | 49 | 6 | 19664392 | |
| Pubmed | 4.50e-15 | 5 | 49 | 5 | 19410616 | ||
| Pubmed | 5.23e-15 | 12 | 49 | 6 | 20371502 | ||
| Pubmed | 5.23e-15 | 12 | 49 | 6 | 20137308 | ||
| Pubmed | 5.23e-15 | 12 | 49 | 6 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 5.23e-15 | 12 | 49 | 6 | 19181658 | |
| Pubmed | 9.69e-15 | 13 | 49 | 6 | 18687225 | ||
| Pubmed | 9.69e-15 | 13 | 49 | 6 | 19934297 | ||
| Pubmed | 9.69e-15 | 13 | 49 | 6 | 19120281 | ||
| Pubmed | 1.69e-14 | 14 | 49 | 6 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 1.69e-14 | 14 | 49 | 6 | 19421224 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.69e-14 | 14 | 49 | 6 | 15896204 | |
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 20082646 | ||
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 20643584 | ||
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 19326408 | ||
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 19926642 | ||
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 2.82e-14 | 15 | 49 | 6 | 20207982 | |
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 19493232 | ||
| Pubmed | 2.82e-14 | 15 | 49 | 6 | 20356536 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 19897003 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 19279038 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 17868255 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 18643961 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 19309280 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 19000141 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 4.51e-14 | 16 | 49 | 6 | 19527230 | |
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 20331834 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 20652381 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 18668235 | ||
| Pubmed | 4.51e-14 | 16 | 49 | 6 | 20210919 | ||
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 20173784 | ||
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 20173792 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 6.96e-14 | 17 | 49 | 6 | 19218127 | |
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 20483367 | ||
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 19968064 | ||
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 19169284 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 6.96e-14 | 17 | 49 | 6 | 20878400 | |
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 20650299 | ||
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 19450876 | ||
| Pubmed | 6.96e-14 | 17 | 49 | 6 | 19761533 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 1.04e-13 | 18 | 49 | 6 | 19046302 | |
| Pubmed | 1.04e-13 | 18 | 49 | 6 | 19846535 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 1.04e-13 | 18 | 49 | 6 | 19630074 | |
| Pubmed | 1.04e-13 | 18 | 49 | 6 | 20519398 | ||
| Pubmed | 1.04e-13 | 18 | 49 | 6 | 20580654 | ||
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 1.52e-13 | 19 | 49 | 6 | 18778326 | |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 1.52e-13 | 19 | 49 | 6 | 18571006 | |
| Pubmed | 1.52e-13 | 19 | 49 | 6 | 20600442 | ||
| Pubmed | 1.52e-13 | 19 | 49 | 6 | 18848853 | ||
| Pubmed | 2.17e-13 | 20 | 49 | 6 | 20426625 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 2.17e-13 | 20 | 49 | 6 | 20193031 | |
| Pubmed | 2.51e-13 | 8 | 49 | 5 | 18681957 | ||
| Pubmed | 3.04e-13 | 21 | 49 | 6 | 19861144 | ||
| Pubmed | 4.18e-13 | 22 | 49 | 6 | 20492596 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 5.64e-13 | 9 | 49 | 5 | 8662091 | |
| Pubmed | 5.64e-13 | 9 | 49 | 5 | 18340360 | ||
| Pubmed | 1.13e-12 | 10 | 49 | 5 | 21206914 | ||
| Pubmed | 2.07e-12 | 11 | 49 | 5 | 18830515 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 2.64e-12 | 29 | 49 | 6 | 20082482 | |
| Pubmed | 8.92e-12 | 14 | 49 | 5 | 19489269 | ||
| Pubmed | 8.92e-12 | 14 | 49 | 5 | 18945962 | ||
| Pubmed | 8.96e-12 | 35 | 49 | 6 | 19683555 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 1.34e-11 | 15 | 49 | 5 | 17498266 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 1.94e-11 | 16 | 49 | 5 | 16403292 | |
| Pubmed | 2.75e-11 | 17 | 49 | 5 | 19032228 | ||
| Pubmed | 3.80e-11 | 18 | 49 | 5 | 20200544 | ||
| Pubmed | 3.80e-11 | 18 | 49 | 5 | 20210918 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 17882223 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 20528243 | ||
| Pubmed | 4.36e-10 | 9 | 49 | 4 | 7749980 | ||
| Pubmed | 4.36e-10 | 9 | 49 | 4 | 18074414 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 12559621 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 1.71e-09 | 12 | 49 | 4 | 17490516 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 23325834 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 19500138 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han. | 2.63e-09 | 3 | 49 | 3 | 22653583 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 29408295 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 8765026 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 21233146 | ||
| Pubmed | Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. | 1.05e-08 | 4 | 49 | 3 | 23394822 | |
| Pubmed | A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis. | 1.05e-08 | 4 | 49 | 3 | 16829306 | |
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 25253288 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 16698429 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 26472014 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 2.62e-08 | 5 | 49 | 3 | 10424431 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 14607943 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 9.16e-08 | 7 | 49 | 3 | 11169255 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 9430220 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.46e-07 | 8 | 49 | 3 | 17200871 | |
| Pubmed | 1.46e-07 | 8 | 49 | 3 | 9430221 | ||
| Pubmed | Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. | 1.94e-06 | 2 | 49 | 2 | 21285369 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 33973882 | ||
| Pubmed | Novel role of presenilins in maturation and transport of integrin beta 1. | 1.94e-06 | 2 | 49 | 2 | 18293935 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8627176 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16135086 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12460542 | ||
| Pubmed | Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. | 1.94e-06 | 2 | 49 | 2 | 8755489 | |
| Pubmed | KIR2DS5 in the presence of HLA-C C2 protects against endometriosis. | 1.94e-06 | 2 | 49 | 2 | 25724317 | |
| Interaction | KIR2DS2 interactions | 1.62e-06 | 37 | 47 | 4 | int:KIR2DS2 | |
| Interaction | KIR2DL2 interactions | 3.34e-06 | 13 | 47 | 3 | int:KIR2DL2 | |
| Interaction | KIR2DS5 interactions | 6.52e-06 | 16 | 47 | 3 | int:KIR2DS5 | |
| Interaction | KIR2DS3 interactions | 1.32e-05 | 20 | 47 | 3 | int:KIR2DS3 | |
| Interaction | KIR2DS1 interactions | 3.18e-05 | 4 | 47 | 2 | int:KIR2DS1 | |
| Interaction | KIR3DP1 interactions | 3.18e-05 | 4 | 47 | 2 | int:KIR3DP1 | |
| Cytoband | 19q13.4 | 2.76e-12 | 79 | 49 | 7 | 19q13.4 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 8.75e-13 | 18 | 37 | 6 | 620 | |
| GeneFamily | Blood group antigens|XK related family | 2.22e-04 | 11 | 37 | 2 | 955 | |
| GeneFamily | ATP binding cassette subfamily A | 3.65e-04 | 14 | 37 | 2 | 805 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 1.45e-06 | 190 | 49 | 6 | M4662 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 2.15e-06 | 49 | 49 | 4 | M40909 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 3.57e-05 | 200 | 49 | 5 | M6208 | |
| Drug | S-182 | 4.35e-06 | 2 | 48 | 2 | CID003033995 | |
| Drug | pristane | 1.69e-05 | 152 | 48 | 5 | CID000015979 | |
| Drug | D-Au | 2.10e-05 | 77 | 48 | 4 | CID000277822 | |
| Drug | Aa1 | 2.83e-05 | 83 | 48 | 4 | CID009549188 | |
| Drug | isopentenyl diphosphate | 3.72e-05 | 89 | 48 | 4 | CID000001195 | |
| Drug | bunazosin | 4.18e-05 | 32 | 48 | 3 | CID000002472 | |
| Drug | N-acetylfucosamine | 4.33e-05 | 5 | 48 | 2 | CID000193723 | |
| Drug | reazide | 4.33e-05 | 5 | 48 | 2 | CID000008820 | |
| Disease | Alzheimer's disease 3 (implicated_via_orthology) | 1.98e-06 | 2 | 42 | 2 | DOID:0110042 (implicated_via_orthology) | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 2.96e-05 | 6 | 42 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Asphyxia Neonatorum | 2.96e-05 | 6 | 42 | 2 | C0004045 | |
| Disease | functional impairment measurement | 4.13e-05 | 7 | 42 | 2 | EFO_0005412 | |
| Disease | Early-onset autosomal dominant Alzheimer disease | 4.13e-05 | 7 | 42 | 2 | cv:CN043596 | |
| Disease | Alzheimer disease | 5.51e-05 | 8 | 42 | 2 | cv:C0002395 | |
| Disease | epilepsy (implicated_via_orthology) | 8.53e-05 | 163 | 42 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | 1-Methylhistidine measurement | 2.65e-04 | 17 | 42 | 2 | EFO_0021543 | |
| Disease | asthma, cardiovascular disease | 8.39e-04 | 30 | 42 | 2 | EFO_0000319, MONDO_0004979 | |
| Disease | Primary dilated cardiomyopathy | 1.08e-03 | 34 | 42 | 2 | cv:C0007193 | |
| Disease | personality trait | 1.42e-03 | 39 | 42 | 2 | EFO_0004365 | |
| Disease | Familial dilated cardiomyopathy | 1.80e-03 | 44 | 42 | 2 | C0340427 | |
| Disease | calcium measurement | 1.91e-03 | 628 | 42 | 5 | EFO_0004838 | |
| Disease | Cardiomyopathy | 2.05e-03 | 47 | 42 | 2 | cv:C0878544 | |
| Disease | Cardiomyopathy, Dilated | 2.14e-03 | 48 | 42 | 2 | C0007193 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.32e-03 | 50 | 42 | 2 | C1449563 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.00e-03 | 57 | 42 | 2 | DOID:10652 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TALRKVLSLKQLLFP | 826 | Q92888 | |
| KKPFLTGLVVFLLIV | 326 | Q8IUA7 | |
| VIKELLKFSPTLGIL | 226 | Q8N6D5 | |
| ISFLIPSLLLLVVFK | 1151 | Q99758 | |
| KQPSILLFQFIKSVL | 396 | Q4ADV7 | |
| SVVKIPFTILLFFLL | 251 | P43631 | |
| LKLICFLIPFLLSLK | 316 | Q7Z5J8 | |
| SVVKIPFTILLFFLL | 251 | P43632 | |
| PIIFLLLDKTFKKTL | 306 | Q96P67 | |
| KTFRLKLPALLALTA | 161 | Q12809 | |
| LLKLSLIRGKSLLFV | 251 | Q9NY93 | |
| GTIFPIIFLLKRLTF | 156 | Q8NGK2 | |
| LASFATPKVILNLLK | 76 | Q8NGC6 | |
| VLLISIPIGFLFKKA | 11 | Q96N66 | |
| SVVKLPFTILLFFLL | 251 | Q14952 | |
| FLFNDLLVILKLCPK | 896 | Q9UPP2 | |
| SVVKLPFTILLFFLL | 251 | Q14953 | |
| VTVNFFIFLKILKLL | 351 | O95838 | |
| KLLKLSVLLPLIFTI | 151 | Q8TDQ1 | |
| KLLLTKRVSPISFFL | 36 | Q8IZF7 | |
| TVCLFLVQKKPLIFL | 986 | Q86Z14 | |
| LLKRDFLKLLPLELS | 51 | Q9UKT8 | |
| FKSFVILFVTPLLLL | 11 | Q86YT5 | |
| LVTPLQLLLFASKKV | 1061 | Q08211 | |
| LFILLKTTFGLKILF | 581 | Q3ZCN5 | |
| ALKVFKLPVEFLLLL | 326 | Q6J4K2 | |
| SVVKIPFTILLFFLL | 251 | Q14954 | |
| QITKLLILKLRYFTP | 331 | O14717 | |
| TLLLLAIFKKALPAL | 421 | P49768 | |
| LRLFPLFVLALLKQK | 896 | O95486 | |
| KKLPKELLLRIFSFL | 26 | Q96IG2 | |
| SVVKIPFTILLFFLL | 346 | Q14943 | |
| TAFTFLKIPQVLVKL | 306 | O75448 | |
| FIKTLLILFKPLISF | 166 | Q07960 | |
| KRTLKVLTFLVLFIF | 6 | Q11201 | |
| TLLSRLKLFLVKDPL | 106 | Q5VXU9 | |
| GLTLLIPYILTLRKK | 921 | Q13621 | |
| LLIFDILKKLIGTFT | 481 | Q5C9Z4 | |
| ILKLYLVSKNFLLPS | 401 | Q9BVR0 | |
| FLPIVVLIFKSILFL | 296 | Q9UHE8 | |
| KVILFLSLLLSPVLK | 6 | Q9Y6N3 | |
| KLLKPILVFAFAIAA | 231 | Q6T4P5 | |
| LSPLSLIFLAKFLKK | 66 | Q8NEB5 | |
| FLLIKKQFPLIISSV | 71 | Q9BTF0 | |
| LTLLLLAVFKKALPA | 401 | P49810 | |
| ILPVRTLLLKFFSKI | 516 | Q9NXF1 | |
| KPITFLSLKLRLVNI | 651 | Q86X10 | |
| FIASLKLKSLPVLLI | 256 | Q5GH77 | |
| KLKSLPVLLIIYFVS | 261 | Q5GH77 | |
| IEKSLLLLKFLPTGI | 1421 | O43149 | |
| FSATLKLKAVPFLVL | 261 | Q6PP77 | |
| KLKAVPFLVLNFLII | 266 | Q6PP77 |